期刊文献+

(2S,4S)-1-烯丙氧羰基-2-(氨磺酰氨基)甲基-4-巯基吡咯烷的合成

Synthesis of(2S,4S)-1-allyl-4-mercapto-2-((sulfamoylamino)-methyl)pyrrolidine-1-carboxylate
下载PDF
导出
摘要 目的烯丙氧羰基保护的多利培南侧链的合成。方法以反式-4-羟基-L-脯氨酸为起始原料,经酯化、N-酰化、甲烷磺酰化、还原、SN2取代反应、Mitsunobu缩合反应、水解7步合成了多利培南关键中间体(2S,4S)-1-烯丙氧羰基-2-(氨磺酰氨基)甲基-4-巯基吡咯烷(1),总收率为32.5%。结果目标化合物和关键中间体经1H-NMR、MS谱确证。结论各步反应操作简便,条件温和,有利于工业化生产。 Objective Synthesis of an important side chain of the novel carbapenem antibiotic doripenem. Methods The side chain of doripenem was synthesized with trans-4-hydroxy-L-proline as a starting material in 7 steps including esterification, N-acylation, methanesulfonyl, reduction reaction, SN2 substitution reaction, Mitsunobu condensation reaction and hydrolysis reaction. The total yield was 32.5%. Results Target compounds and key intermediates were evidenced by 1H-NMR and MS spectrum. Conclusion The reactions are easy to operate under mild conditions, and can be conducive to industrial production.
出处 《中国抗生素杂志》 CAS CSCD 北大核心 2013年第11期831-833,858,共4页 Chinese Journal of Antibiotics
基金 国家"重大新药创制"科技重大专项(2011ZX09202-101-14)
关键词 碳青霉烯 抗生素 多利培南中间体 合成 1β-methylacarbapenem Antibiotic Intermediates of doripenem Synthesis
  • 相关文献

参考文献12

  • 1Johnston D, Schmitt S M, Bouffard F A, et al. Total synthesis of (+-)-thienamycin[J]. JAm Chem. Soe, 1978, 100(1): 313-315.
  • 2张致平.β-内酰胺类抗生素研究的进展(Ⅰ)[J].中国抗生素杂志,2000,25(2):81-86. 被引量:39
  • 3张淑华,刘浚.碳青霉烯类抗生素[J].四川生理科学杂志,1997,19(1):9-13. 被引量:1
  • 4刘光荣,蒋晨.抗MRSA有效的β-甲基碳青霉烯类衍生物研究进展[J].国外医药(抗生素分册),2004,25(6):253-257. 被引量:1
  • 5西谷康宏,入江忠司.吡咯烷衍生物制备方法:CN,1113233A[P].1992-08-20.
  • 6蒋旭东,曹旭峰,袁哲东,俞雄,周伟澄.新型1β-甲基碳青霉烯母核的合成[J].中国抗生素杂志,2011,36(2):132-134. 被引量:2
  • 7Yutaka N, Tadafumi K, Tetsuya Y, et al. Practical Large- Scale Synthesis of the 2-Aminomethylpyrrolidin-4-ylthio- Containing Side Chain of the Novel Carbapenem Antibiotic Doripenem[J]. Org Proc Res Dev, 2003, 7: 649-654.
  • 8Chen K M, Randolph, Goetz E. Hardtmann.Processes for synthesis of diprotected R[R,S]-3,5-Dihyproxy-6- oxohexanoate esters: US,4870199[P]. 1988-05-10.
  • 9Yasuhiro N, Tadashi I, Yutaka N,et al. A pyrrolidylthio- carbapenem derivative: EP,0528678[P]. 1993-02-24.
  • 10Masaaki U, Yasuyuki H, Kouichi N, et al. Process for production of carbapenem derivative and crystalline intermediate therefor: WO,2006087996A1 [P]. 2006-08-24.

二级参考文献30

  • 1卫敬星.意象复叠与符号隐喻:微电影《龙头》解读[J].电影评介,2013(10):42-43. 被引量:2
  • 2张爱艳,朱雪焱,袁哲东.多尼培南的合成[J].中国医药工业杂志,2006,37(6):361-363. 被引量:6
  • 3Kawamoto I. 1β-Methylcarbapenem antibiotics[J]. Drug Future, 1998, 23(2): 181-189.
  • 4Lee J H, Lee K S, Kang Y K, et al. Synthesis and biological activity of novel 1β-methylcarbapenems with oxyiminopyrrolidinylamide moiety[J]. Bioorg Med Chem Lett, 2003, 13(24): 4399-4403.
  • 5Ueda Y, Itoh M, Sasaki A, et al. SM-216601, a novel parenteral 1β-methylcarbapenem: structure-activity relationships of antibacterial activity and neurotoxicity in mice[J]. JAntibiot, 2005, 58(2): 118-140.
  • 6Satoshi K. Carbapenem compound: JP20050319343[P]. 2005-11-02.
  • 7Deziel R, Endo M. An expeditious synthesis of a 1β- methylcarbapenem key intermediate[J]. Tetrahedron Left, 1988, 29(1): 61-64.
  • 8Christensen B G, Ratcliffe R W, Chabala J C. 2-Aza- substituted 1-carbadethiapen-2-EM-3-carboxylic acids: EP0208889[P]. 1987-01-21.
  • 9Yoshihiro N, Tamio H. Production of azctidinonc compound: JP8311092[P]. 1996-11-26.
  • 10Diekema DJ,Pfulle MA,Schmitz EJ,et al.Survey of infections due to Staphylococcus species: frequency of occurrence and anti-microbial susceptibility of isolates collected in the United States,Canada,Latin Amerca,Euope,and the Western Pacific region for the

共引文献39

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部